Posted on

Brain tumors by Francis Ali-Osman

By Francis Ali-Osman

Show description

Read Online or Download Brain tumors PDF

Similar diseases books

Immunotherapy in 2020: Visions and Trends for Targeting Inflammatory Disease (Ernst Schering Foundation Symposium Proceedings 06.4)

This quantity beneficial properties contributions from contributors of the ESRF symposium on "Immunotherapy in 2020—Visions and traits for concentrating on Inflammatory illnesses" held in Potsdam close to Berlin, Germany, in October 2006. The symposium shows coated the most mechanisms of immunoregulation resembling peripheral and significant tolerance, epigenetic programming, immunologic reminiscence, and regulatory networks in irritation in addition to novel experimental and scientific ways for concentrating on irritation in autoimmunity and transplantation.

Neglected Diseases: A Human Rights Analysis (Special Topics) (Special Topics)

This document is the results of collaboration among the precise Programme for learn and coaching in Tropical ailments (TDR), the excessive Commissioner for Human Rigths (HHR) group and the United countries (UN) distinct Rapporteur at the correct of everybody to the top possible typical of future health. ignored ailments are either a reason and final result of human rights violations.

Virus Diseases in Laboratory and Captive Animals

The effect of uncomplicated technology, relatively molecular biology, in human and veterinary medication revolutionized pondering in lots of points and altered essentially and creatively the classical technique for examine and prevention of infectious illnesses. Genetic engineering and comparable disciplines have advanced to a outstanding measure during the last decade and now shape the keystone helping medication.

Additional resources for Brain tumors

Sample text

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA 91:7727–7731. 55. Y. 1998. The molecular genetics of central nervous system tumors. Pathology 30:196–202. 56. , Lois A, et al. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753–756. 57. D. , et al. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362:857–860. 58. , et al. 1998. Gene amplification as a prognostic factor in primary brain tumors.

3 (70,79), allowing for candidate genes within this region to be examined for mutation. The incidence of 19q deletion is not significantly different between low- and high-grade oligodendrogliomas, suggesting that this alteration is an early event in the neoplastic development of these tumors (68). This finding contrasts with the 19q loss observed in astrocytic gliomas that is generally restricted to the high-grade cases (79). Deletion of chromosome 1p is another frequent event in oligodendrogliomas, occurring in 40– 90% of these tumors (2,68).

Et al. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849. 50. , et al. 1997. P-TEN, the tumor suppressor from human chromosome 10q23, is a dualspecificity phosphatase. Proc. Natl. Acad. Sci. USA 94:9052–9057. 51. , et al. 1998. Drug resistance of human glioblastoma cells conferred by a tumorspecific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci. USA 95:5724–5729.

Download PDF sample

Rated 4.06 of 5 – based on 9 votes